Thuja Capital

You are here > Home > Team

Team

The funds of Thuja Capital are managed by Thuja Capital Management B.V., which consists of Harrold van Barlingen and Michel Briejer. They are actively supported by a scientific advisory board consisting of highly seasoned experts with a scientific and/or industrial/business background.

Thuja Capital: the only independent life sciences venture capital investor with a focus on start-up and early stage life sciences companies located in the Benelux

• Team
  • Investment Management
  • Scientific Advisory Board

• News

  • Amsterdam, The Netherlands - DCPrime today announced that the Committee for Orphan Medical Products (COMP) of the European Medicines Agency has issued a positive opinion Read further …

  • Rotterdam, The Netherlands – arGEN-X announced today that it has closed an oversubscribed series B financing round of 27.5 mio Euro Read further …

  • Utrecht, The Netherlands - The Dutch financial newspaper “Het Financieele Dagblad” today published an article on Thuja Capital and DCPrime. Read further …

• Events

  • Harrold van Barlingen will lecture on venture capital at the BioBusiness Masterclass session of  March 15, 2012

  • Harrold will teach on venture capital at the UU & UMCU Valorisation Training session, on Friday March 16, 2012